Patent Notice

Pearson is a leading provider of educational materials, learning technologies, educational software and system-wide solutions, and assessment development, processing, and scoring services.  The following Pearson products and services are protected by patents in the U.S. and elsewhere.
This page is intended to serve as notice under 35 U.S.C. § 287(a).

PreK-12 Education     Higher Education     Clinical Assessment     Academic Assessment
Professional Assessment

PreK-12 Education

ePen U.S. Pat. Nos. 5,321,611; 5,433,615; 5,437,554; 5,458,493; 5,558,521; 5,672,060; 5,690,497; 5,709,551; 5,716,213; 5,718,591; 5,737,694; 5,752,836; 5,987,149; 6,155,839; 6,159,018; 6,168,440; 6,183,260; 6,183,261; 6,193,521; 6,256,399; 6,466,683; 6,558,166; 6,751,351; 6,810,232; 6,961,482; 6,988,895.
TestNav U.S. Pat. No. 9,105,194.
Additional patents may be pending in the U.S. and elsewhere.

Higher Education

Learning Catalytics U.S. Pat. Nos. 8,914,373; 9,219,998.
LearningStudio U.S. Pat. Nos. 6,470,171; 6,674,992; 6,678,500; 6,684,053; 6,965,752; 8,380,121.
MyLab & Mastering U.S. Pat. Nos. 6,470,171; 6,674,992; 6,678,500; 6,684,053; 6,965,752; 8,380,121; 8,755,737.
REVEL U.S. Pat. Nos. 6,470,171; 6,674,992; 6,678,500; 6,684,053; 6,965,752; 8,380,121.
Additional patents may be pending in the U.S. and elsewhere.

Clinical Assessment

Cogmed U.S. Pat. No. 7,186,116.
Quotient ADHD System U.S. Pat. Nos. 6,685,652; 7,942,828; 8,078,253; 9,050,032; D620,725; D661,810.
Additional patents may be pending in the U.S. and elsewhere.

Academic Assessment

ePen U.S. Pat. Nos. 5,321,611; 5,433,615; 5,437,554; 5,458,493; 5,558,521; 5,672,060; 5,690,497; 5,709,551; 5,716,213; 5,718,591; 5,737,694; 5,752,836; 5,987,149; 6,155,839; 6,159,018; 6,168,440; 6,183,260; 6,183,261; 6,193,521; 6,256,399; 6,466,683; 6,558,166; 6,751,351; 6,810,232; 6,961,482; 6,988,895.
TestNav U.S. Pat. No. 9,105,194.
Additional patents may be pending in the U.S. and elsewhere.

Professional Assessment

Versant U.S. Pat. No. 7,062,441.
VUE U.S. Pat. No. D472,397.
Additional patents may be pending in the U.S. and elsewhere.